FDA, industry preaching opposing CBD narratives on Capitol Hill
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).
Stay updated with breaking news from Cv Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).
CV Sciences, Inc. (OTCMKTS:CVSI – Free Report) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 15,000 shares, a decrease of 42.5% from the May 31st total of 26,100 shares. Based on an average daily volume of 206,600 shares, the short-interest ratio is […]
CV Sciences, Inc. (OTCMKTS:CVSI – Free Report) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 15,000 shares, a drop of 42.5% from the May 31st total of 26,100 shares. Based on an average daily trading volume, of 206,600 shares, […]
CV Sciences, Inc. (OTCMKTS:CVSI – Get Rating) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 26,100 shares, a decline of 39.9% from the May 15th total of 43,400 shares. Based on an average trading volume of 385,600 shares, the […]
CV Sciences, Inc. (OTCMKTS:CVSI – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 26,100 shares, a decrease of 39.9% from the May 15th total of 43,400 shares. Based on an average daily trading volume, of 385,600 shares, the days-to-cover ratio […]